99 related articles for article (PubMed ID: 16563764)
1. Synthesis and biological investigations of dopaminergic partial agonists preferentially recognizing the D4 receptor subtype.
Löber S; Hübner H; Gmeiner P
Bioorg Med Chem Lett; 2006 Jun; 16(11):2955-9. PubMed ID: 16563764
[TBL] [Abstract][Full Text] [Related]
2. Click chemistry based synthesis of dopamine D4 selective receptor ligands for the selection of potential PET tracers.
Banerjee A; Maschauer S; Hübner H; Gmeiner P; Prante O
Bioorg Med Chem Lett; 2013 Nov; 23(22):6079-82. PubMed ID: 24100078
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D2, D3, and D4 selective phenylpiperazines as molecular probes to explore the origins of subtype specific receptor binding.
Ehrlich K; Götz A; Bollinger S; Tschammer N; Bettinetti L; Härterich S; Hübner H; Lanig H; Gmeiner P
J Med Chem; 2009 Aug; 52(15):4923-35. PubMed ID: 19606869
[TBL] [Abstract][Full Text] [Related]
4. New generation dopaminergic agents. 1. Discovery of a novel scaffold which embraces the D2 agonist pharmacophore. Structure-activity relationships of a series of 2-(aminomethyl)chromans.
Mewshaw RE; Kavanagh J; Stack G; Marquis KL; Shi X; Kagan MZ; Webb MB; Katz AH; Park A; Kang YH; Abou-Gharbia M; Scerni R; Wasik T; Cortes-Burgos L; Spangler T; Brennan JA; Piesla M; Mazandarani H; Cockett MI; Ochalski R; Coupet J; Andree TH
J Med Chem; 1997 Dec; 40(26):4235-56. PubMed ID: 9435894
[TBL] [Abstract][Full Text] [Related]
5. A-412997 is a selective dopamine D4 receptor agonist in rats.
Moreland RB; Patel M; Hsieh GC; Wetter JM; Marsh K; Brioni JD
Pharmacol Biochem Behav; 2005 Sep; 82(1):140-7. PubMed ID: 16153699
[TBL] [Abstract][Full Text] [Related]
6. Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors.
Depoortère R; Bardin L; Rodrigues M; Abrial E; Aliaga M; Newman-Tancredi A
Behav Pharmacol; 2009 Jul; 20(4):303-11. PubMed ID: 19584712
[TBL] [Abstract][Full Text] [Related]
7. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.
Heinrich JN; Brennan J; Lai MH; Sullivan K; Hornby G; Popiolek M; Jiang LX; Pausch MH; Stack G; Marquis KL; Andree TH
Eur J Pharmacol; 2006 Dec; 552(1-3):36-45. PubMed ID: 17056032
[TBL] [Abstract][Full Text] [Related]
8. 18F-Labeled FAUC 346 and BP 897 derivatives as subtype-selective potential PET radioligands for the dopamine D3 receptor.
Hocke C; Prante O; Salama I; Hübner H; Löber S; Kuwert T; Gmeiner P
ChemMedChem; 2008 May; 3(5):788-93. PubMed ID: 18306190
[TBL] [Abstract][Full Text] [Related]
9. Clozapine derived 2,3-dihydro-1H-1,4- and 1,5-benzodiazepines with D4 receptor selectivity: synthesis and biological testing.
Hussenether T; Hübner H; Gmeiner P; Troschütz R
Bioorg Med Chem; 2004 May; 12(10):2625-37. PubMed ID: 15110844
[TBL] [Abstract][Full Text] [Related]
10. 1-aryl-3-(4-pyridine-2-ylpiperazin-1-yl)propan-1-one oximes as potent dopamine D4 receptor agonists for the treatment of erectile dysfunction.
Kolasa T; Matulenko MA; Hakeem AA; Patel MV; Mortell K; Bhatia P; Henry R; Nakane M; Hsieh GC; Terranova MA; Uchic ME; Miller LN; Chang R; Donnelly-Roberts DL; Namovic MT; Hollingsworth PR; Martino B; El Kouhen O; Marsh KC; Wetter JM; Moreland RB; Brioni JD; Stewart AO
J Med Chem; 2006 Aug; 49(17):5093-109. PubMed ID: 16913699
[TBL] [Abstract][Full Text] [Related]
11. Fancy bioisosteres: metallocene-derived G-protein-coupled receptor ligands with subnanomolar binding affinity and novel selectivity profiles.
Schlotter K; Boeckler F; Hübner H; Gmeiner P
J Med Chem; 2005 Jun; 48(11):3696-9. PubMed ID: 15916420
[TBL] [Abstract][Full Text] [Related]
12. 2-[(4-phenylpiperazin-1-yl)methyl]imidazo(di)azines as selective D4-ligands. Induction of penile erection by 2-[4-(2-methoxyphenyl)piperazin-1-ylmethyl]imidazo[1,2-a]pyridine (PIP3EA), a potent and selective D4 partial agonist.
Enguehard-Gueiffier C; Hübner H; El Hakmaoui A; Allouchi H; Gmeiner P; Argiolas A; Melis MR; Gueiffier A
J Med Chem; 2006 Jun; 49(13):3938-47. PubMed ID: 16789750
[TBL] [Abstract][Full Text] [Related]
13. Functional activation by central monoamines of human dopamine D(4) receptor polymorphic variants coupled to GIRK channels in Xenopus oocytes.
Wedemeyer C; Goutman JD; Avale ME; Franchini LF; Rubinstein M; Calvo DJ
Eur J Pharmacol; 2007 May; 562(3):165-73. PubMed ID: 17350612
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and dopamine D4 receptor binding activities of new N-heteroaromatic 5/6-ring Mannich bases.
Linz S; Müller J; Hübner H; Gmeiner P; Troschütz R
Bioorg Med Chem; 2009 Jul; 17(13):4448-58. PubMed ID: 19481941
[TBL] [Abstract][Full Text] [Related]
15. A theoretical study to investigate D2DAR/D4DAR selectivity: receptor modeling and molecular docking of dopaminergic ligands.
Ortore G; Tuccinardi T; Bertini S; Martinelli A
J Med Chem; 2006 Feb; 49(4):1397-407. PubMed ID: 16480275
[TBL] [Abstract][Full Text] [Related]
16. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
[TBL] [Abstract][Full Text] [Related]
17. Pharmacophore-guided drug discovery investigations leading to bioactive 5-aminotetrahydropyrazolopyridines. Implications for the binding mode of heterocyclic dopamine D3 receptor agonists.
Elsner J; Boeckler F; Heinemann FW; Hübner H; Gmeiner P
J Med Chem; 2005 Sep; 48(18):5771-9. PubMed ID: 16134944
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling.
Jordan S; Johnson JL; Regardie K; Chen R; Koprivica V; Tadori Y; Kambayashi J; Kitagawa H; Kikuchi T
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):348-56. PubMed ID: 17070976
[TBL] [Abstract][Full Text] [Related]
19. A-412997, a selective dopamine D4 agonist, improves cognitive performance in rats.
Browman KE; Curzon P; Pan JB; Molesky AL; Komater VA; Decker MW; Brioni JD; Moreland RB; Fox GB
Pharmacol Biochem Behav; 2005 Sep; 82(1):148-55. PubMed ID: 16154186
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel lactam derivatives and their evaluation as ligands for the dopamine receptors, leading to a D(4)-selective ligand.
Awadallah FM; Müller F; Lehmann J; Abadi AH
Bioorg Med Chem; 2007 Sep; 15(17):5811-8. PubMed ID: 17576067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
